Literature DB >> 25478606

First trials for Ebola treatments announced.

Dara Mohammadi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25478606     DOI： 10.1016/s0140-6736(14)62043-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Ebola research funding: a systematic analysis, 1997-2015.

Authors:  Joseph Ra Fitchett; Amos Lichtman; Damilola T Soyode; Ariel Low; Jimena Villar de Onis; Michael G Head; Rifat Atun
Journal:  J Glob Health       Date:  2016-12       Impact factor: 4.413

2.  Responding to ever-changing epidemiological dynamics of Ebola virus disease.

Authors:  Yuki Maehira; Yohei Kurosaki; Tomoya Saito; Jiro Yasuda; Masayoshi Tarui; Denis J M Malvy; Tsutomu Takeuchi
Journal:  BMJ Glob Health       Date:  2016-11-24

3.  Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea.

Authors:  Rafael Van den Bergh; Pascale Chaillet; Mamadou Saliou Sow; Mathieu Amand; Charlotte van Vyve; Sylvie Jonckheere; Rosa Crestani; Armand Sprecher; Michel Van Herp; Arlene Chua; Erwan Piriou; Lamine Koivogui; Annick Antierens
Journal:  Emerg Infect Dis       Date:  2016-02       Impact factor: 6.883

4.  Ebola Virus Diseases in Africa: a commentary on its history, local and global context.

Authors:  Paschal Kum Awah; Alphonse Um Boock; Kaiseuh Awah Kum
Journal:  Pan Afr Med J       Date:  2015-10-11

5.  What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea.

Authors:  Maya Ronse; Almudena Marí Sáez; Charlotte Gryseels; Melanie Bannister-Tyrrell; Alexandre Delamou; Alain Guillard; Mustapha Briki; Frédéric Bigey; Nyankoye Haba; Johan van Griensven; Koen Peeters Grietens
Journal:  PLoS Negl Trop Dis       Date:  2018-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.